Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 3,537 | 2,395 | 951 | 1,043 | 39,567 |
| Cost of Goods | N/A | 207 | 336 | 5 | 27 |
| Gross Profit | 3,537 | 2,188 | 615 | 1,038 | 39,540 |
| Operating Expenses | 12,081 | 11,561 | 11,313 | 12,672 | 15,154 |
| Operating Income | -8,544 | -9,166 | -10,362 | -11,629 | 24,413 |
| Other Income | -584 | -574 | -536 | -554 | -367 |
| Pre-tax Income | -9,128 | -9,740 | -10,898 | -12,183 | 24,046 |
| Net Income Continuous | -9,128 | -9,740 | -10,898 | -12,183 | 24,046 |
| Net Income | $-9,128 | $-9,740 | $-10,898 | $-12,183 | $24,046 |
| EPS Basic Total Ops | -0.20 | -0.24 | -0.27 | -0.31 | 0.61 |
| EPS Basic Continuous Ops | -0.20 | -0.24 | -0.28 | -0.31 | 0.61 |
| EPS Diluted Total Ops | -0.20 | -0.24 | -0.26 | -0.31 | 0.60 |
| EPS Diluted Continuous Ops | -0.20 | -0.24 | -0.26 | -0.31 | 0.60 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.24 | -0.28 | -0.31 | 0.65 |
| EBITDA(a) | $-7,171 | $-7,763 | $-8,985 | $-10,285 | $25,659 |